跳至主要内容
临床试验/ACTRN12613000767707
ACTRN12613000767707已完成不适用

Comparative efficacy of Meloxicam and placebo on vasospasm in patients with subarachnoid hemorrhage (SAH) in Shariati Hospital

Tehran University of Medical Sciences0 个研究点目标入组 106 人开始时间: 2013年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Patients with diagnosis of subarachnoid hemorrhage documented by Computed Tomography (CT) scan who admitted to neurosurgery and neurology wards of Shariati hospital.

排除标准

  • Meloxicam contraindications: Meloxicam, aspirin, or any other NSAIDs sensitivity
  • Serious adverse reaction induced by meloxicam
  • Long term use of meloxicam or any other NSAIDs before the study
  • Occurrence of rebleeding in patient leading to emergency neurosurgical operation
  • Serious interaction between patient's medications and meloxicam
  • Unstable hemodynamic condition in patient making doppler sonography impossible

研究者

相似试验